Year |
Citation |
Score |
2020 |
Tripoli G, Quattrone D, Ferraro L, Gayer-Anderson C, Rodriguez V, La Cascia C, La Barbera D, Sartorio C, Seminerio F, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Llorca PM, ... ... Os JV, et al. Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study. Psychological Medicine. 1-11. PMID 32327005 DOI: 10.1017/S003329171900357X |
0.355 |
|
2019 |
Menghini-Müller S, Studerus E, Ittig S, Heitz U, Egloff L, Andreou C, Valmaggia LR, Kempton MJ, van der Gaag M, de Haan L, Nelson B, Barrantes-Vidal N, Nordentoft M, Ruhrmann S, Sachs G, ... ... Os JV, et al. Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study. European Psychiatry : the Journal of the Association of European Psychiatrists. 59: 52-59. PMID 31075522 DOI: 10.1016/J.Eurpsy.2019.04.007 |
0.412 |
|
2018 |
Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, ... ... Os JV, et al. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. The British Journal of Psychiatry : the Journal of Mental Science. 213: 535-541. PMID 30113282 DOI: 10.1192/Bjp.2018.89 |
0.474 |
|
2015 |
Duinen MV, Reneerkens OA, Lambrecht L, Sambeth A, Rutten BP, Os JV, Blokland A, Prickaerts J. Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction. Current Pharmaceutical Design. 21: 3813-28. PMID 26044976 |
0.365 |
|
2015 |
Os JV, Boevink W. [Discussion about the non-existence of schizophrenia; is there an elephant in the room?]. Tijdschrift Voor Psychiatrie. 57: 284-7. PMID 25970879 |
0.391 |
|
2012 |
Tenback D, Pijl B, Smeets H, Os Jv, Harten Pv. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study. Journal of Clinical Psychopharmacology. 32: 31-5. PMID 22198442 DOI: 10.1097/JCP.0b013e31823f3c43 |
0.383 |
|
2005 |
Henquet C, Murray R, Linszen D, Os Jv. The Environment and Schizophrenia: The Role of Cannabis Use Schizophrenia Bulletin. 31: 608-612. PMID 15976013 DOI: 10.1093/Schbul/Sbi027 |
0.351 |
|
2005 |
Krabbendam L, Myin-Germeys I, Hanssen M, Graaf Rd, Vollebergh W, Bak M, Os Jv. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology. 44: 113-125. PMID 15826348 DOI: 10.1348/014466504X19767 |
0.334 |
|
Show low-probability matches. |